M. Lergenmüller, T. Nukada, K. Kuramochi, A. Dan, T. Ogawa, Y. Ito
FULL PAPER
treated at 0°C with 28% NaOMe solution in methanol (20 µL,
0.1 mmol), gradually warmed to room temperature and stirred for
30 h. Concentration to dryness and coevaporation with CH2Cl2
(10 mL) left a brownish foam, which was levulinoylated by dissolv-
4Ј, C-5Ј), 82.5 (C-1Ј), 97.8 (C-1), 101.4 (CH3OC6H4CH, C6H5CH),
113.9, 114.4, 118.8 (CH3OC6H4, CH3OC6H4CH), 125.4Ϫ138.6
(C6H5CH, C6H5CH2), 150.7, 155.5, 160.4 (DCPhth, CH3OC6H4),
169.8 (CH3CO). Ϫ C59H57Cl2NO15S (1123.1): calcd. C 63.10, H
ing the intermediate in pyridine (10 mL), adding a 1 levulinic 5.12, N 1.25; found C 63.21, H 5.11, N 1.27.
anhydride solution in CH2Cl2 (5.5 mL, 5.5 mmol) and stirring the
(S)-p-Methoxybenzaldehyde [p-Methoxyphenyl 3,6-di-O-benzyl-2,4-
dideoxy-2-(4,5-dichlorophthalimido)-β- -glucopyranosid-4-yl] (Methyl
4,6-O-benzylidene-2-deoxy-1-thio-3-O-toluyl-␣- -mannopyranosid-
mixture for 4 d at room temperature. The solution was poured into
ice/water (100 mL), stirred for 30 min and extracted with CH2Cl2
(250 mL). The organic layer was washed with 2 HCl (2 ϫ 50 mL),
satd. NaHCO3 solution (50 mL), dried (Na2SO4), and concentrated
to give a brown syrup (1.4 g). Elution from silica gel with toluene/
D
D
2-yl) Acetal (31): This compound was prepared by treatment of
compounds 28 (150 mg, 0.23 mmol) and 24 (170 mg, 0.32 mmol)
with DDQ (123 mg, 0.54 mmol) in anhydrous CH2Cl2 (2.3 mL) in
an analogous manner as described for 30. Purification by size ex-
clusion chromatography (Bio-Beads S-X2) with toluene afforded
184 mg (66%) of 31 as a colorless foam, [α]D ϭ ϩ17.4 (c ϭ 1.1,
CHCl3). Ϫ 1H NMR (270 MHz, CDCl3): δ ϭ 2.11 (s, 3 H, CH3S),
2.38 (s, 3 H, CH3C6H4CO), ca. 3.60 (m, 1 H, 5-H), 3.62 (s, 3 H,
CH3OC6H4), 3.70 (dd, 1 H, 6-Ha), 3.72 (s, 3 H, CH3OC6H4), 3.81
(dd, 1 H, 6-Hb), 3.98 (dd, 1 H, 6Ј-Ha), 4.11 (d, 1 H, 2Ј-H),
4.31Ϫ4.39 (m, 4 H, 3-H, 4-H, 5Ј-H, 6Ј-Hb), 4.42 (dd, 1 H, 4Ј-H),
4.46 (dd, 1 H, 2-H), 4.55, 4.59, 4.81 (3 d, 1 H each, C6H5CH2),
5.09 (s, 1 H, C6H5CH), 5.36 (d, 1 H, C6H5CH2), 5.40 (dd, 1 H, 3Ј-
H), 5.49 (s, 1 H, CH3OC6H4CH), 5.58 (d, 1 H, 1-H), 5.78 (br. s, 1
H, 1Ј-H), 6.40 (d, 1 H, CH3C6H4CH), 6.72, 6.83 (2 m, 2 H each,
AcOEt (5:1) afforded 905 mg (82%) 26 as a colorless foam, [α]D
ϭ
ϩ50.4 (c ϭ 1.0, CHCl3). Ϫ 1H NMR (270 MHz, CDCl3): δ ϭ 2.07
(s, 3 H, CH3S), 2.10 (s, 3 H, CH3Lev), 2.64 (m, 4 H, CH2Lev), 3.63
(s, 3 H, CH3OC6H4CH2), 3.66Ϫ3.91 and 4.10Ϫ4.27 (2 m, 6 H and
4 H, 2-H, 3-H, 4-H, 5-H, 6-H2, 4Ј-H, 5Ј-H, 6Ј-H2), 3.96 (3Ј-H),
4.45, 4.48 (3 d, 1 H each, C6H5CH2 and CH3OC6H4CH2), 4.59 (s,
2 H, C6H5CH2), 4.64, 4.67, 4.87 (3 d, 1 H each, C6H5CH2 and
CH3OC6H4CH2), 5.15 (d, 1 H, 1-H), 5.27 (d, 1 H, 1Ј-H), 5.56 (dd,
1 H, 2Ј-H), 5.61 (s, 1 H, C6H5CH), 6.77 (m, 2 H, CH3OC6H4CH2),
7.16Ϫ7.47 (m, 22 H, C6H5CH2, C6H5CH, and CH3OC6H4CH2);
J1,2 ϭ 1.0, J1Ј,2Ј ϭ 1.8, J2Ј,3Ј ϭ 3.2, J3Ј,4Ј ϭ 8.4 Hz. Ϫ 13C NMR
(67.80 MHz, CDCl3): δ ϭ 13.7 (CH3S), 28.1 (CH2Lev), 29.7
(CH3Lev), 38.0 (CH2Lev), 55.0 (CH3OC6H4CH2), 68.3 (C-2Ј), 68.5,
68.8 (C-6, C-6Ј), 71.3, 72.5, 73.3, 75.1 (C6H5CH2, CH3OC6H4CH2),
77.7 (C-3Ј), 84.7 (C-1), 98.7 (C-1Ј), 101.2 (C6H5CH), 113.9
CH3OC6H4), 6.89Ϫ7.02 (2 d,
2
H
each, CH3C6H4CO,
CH3OC6H4CH), 7.11Ϫ7.39 (m, 15 H, 2 C6H5CH2, C6H5CH), 7.74
(d, 2 H, CH3C6H4CO), 7.75, 7.90 (2 br. s, 1 H each, DCPhth);
(CH3OC6H4CH2),
126.0Ϫ138.4
(C6H5CH2,C6H5CH,
J1,2 ϭ 8.3, J2,3 ϭ 9.4, J1Ј,2Ј < 0.5, J2Ј,3Ј ϭ 3.1, J3Ј,4Ј ϭ 9.9, J4Ј,5Ј
ϭ
CH3OC6H4CH2), 159.3 (CH3OC6H4CH2), 171.6 (CH2COO), 206.0
(CH3CO), 64.4, 72.0, 73.3, 74.3, 78.3, 79.0 (C-2, C-3, C-4, C-5, C-
4Ј, C-5Ј). Ϫ C54H60O13S (949.1): calcd. C 68.34, H 6.37; found C
67.93, H 6.28.
10.2, J6Јa,b ϭ 11.6, JCH2 ϭ 12.2 Hz. Ϫ C65H61Cl2NO15S (1199.2):
calcd. C 65.10, H 5.13, N 1.17; found C 65.15, H 5.08, N 1.46.
(S)-p-Methoxybenzaldehyde {p-Methoxyphenyl O-[3,6-di-O-benzyl-
2,4-dideoxy-2-(4,5-dichlorophthalimido)-β-
(1Ǟ4)-3,6-di-O-benzyl-2-deoxy-2-(4,5-dichlorophthalimido)-β-
glucopyranosid-4-yl} [Methyl O-(3,4,6-tri-O-benzyl-2-O-levulinoyl-
1-thio-α- -mannopyranosyl)-(1Ǟ3)-4,6-O-benzylidene-2-deoxy-1-
pyranosid-2-yl) Acetal (30): A solution of compounds 28 (100 mg, thio-␣- -mannopyranosid-2-yl] Acetal (32): Prepared from com-
D-glucopyranos-4-yl]-
(S)-p-Methoxybenzaldehyde [p-Methoxyphenyl 3,6-di-O-benzyl-
D-
2,4-dideoxy-2-(4,5-dichlorophthalimido)-β-
(Methyl 3-O-acetyl-4,6-O-benzylidene-2-deoxy-1-thio-␣-
D
-glucopyranosid-4-yl]
-manno-
D
D
D
0.15 mmol) and 23 (83 mg, 0.18 mmol) in anhydrous CH2Cl2
(1.5 mL) was stirred in the presence of freshly activated 4-A molec-
pounds 29 (560 mg, 0.46 mmol) and 26 (620 mg, 0.65 mmol) by
treatment with DDQ (253 mg, 1.12 mmol) in CH2Cl2 (5 mL) in an
˚
ular sieves for 30 min under exclusion of light at 0°C. DDQ (68 mg, analogous manner to that described for 30. Purification by size
0.30 mmol) was then added and the deep green mixture was al-
lowed to warm up to room temperature. After stirring for 2 h, the
reaction was quenched by addition of a solution of ascorbic acid
exclusion chromatography (Bio-Beads S-X1) with toluene afforded
790 mg (80%) of 32 as a yellowish foam, [α]D ϭ ϩ26.4 (c ϭ 1.6,
CHCl3). Ϫ 1H NMR (270 MHz, CDCl3): δ ϭ 1.84 (s, 3 H, CH3S),
(0.7%)/citric acid (1.3%)/NaOH (0.9%) in water (7 mL), stirred un- 2.07 (s, 3 H, CH3Lev), 2.59 (s, 4 H, CH2Lev), 3.26 (s, 3 H,
til the color turned to bright yellow (10 min) and diluted with
CH2Cl2 (50 mL). The organic phase was washed with satd.
NaHCO3 solution (10 mL), dried (Na2SO4), and the volatiles were
removed in vacuo to give 150 mg (89%) of crude product. Purifi-
cation by size exclusion chromatography (Bio-Beads S-X2) with
CH3OC6H4CH), 3.32 and 3.41Ϫ3.63 (ddd and m, 1 H and 6 H,
ring protons), 3.67 (s, 3 H, CH3OC6H4), 3.69Ϫ3.76 (m, 3 H, ring
protons, 3ЈЈЈ-H), 3.78 (br. dd, 1 H, 2ЈЈ-H), 3.95, 4.07 (dd and d, 1
H each, ring protons) 4.12Ϫ4.49 (m, 16 H, ring protons, 2-H, 2Ј-
H), 4.54 (d, 2 H, C6H5CH2), 4.63 (br. s, 2 H, C6H5CH2), 4.81, 4.89
(2 d, 1 H each, C6H5CH2), 5.09 (s, 1 H, C6H5CH), 5.21 (d, 1 H,
toluene afforded 109 mg (65%) of 30 as a colorless foam, [α]D
ϭ
ϩ44.2 (c ϭ 0.65, CHCl3). Ϫ 1H NMR (270 MHz, CDCl3): δ ϭ 1ЈЈЈ-H), 5.34 (d, 1 H, 1Ј-H), 5.36 (d, 1 H, C6H5CH2), 5.43 (d, 1 H,
1.83 (s, 3 H, CH3CO), 2.09 (s, 3 H, CH3S), 3.64 (m, 1 H, 5-H), 1-H), 5.50 (br. dd, 1 H, 2ЈЈЈ-H), 5.64 (s, 1 H, CH3OC6H4CH), 5.69
3.72 (s, 3 H, CH3OC6H4), 3.74 (dd, 1 H, 6-Ha), 3.80 (s, 3 H, (s, 1 H, 1ЈЈ-H), 6.61Ϫ6.79 (m, 6 H, CH3OC6H4, CH3OC6H4CH),
CH3OC6H4), 3.82 (dd, 1 H, 6-Hb), 3.92 (m, 2 H, 2Ј-H, 6Ј-Ha), 6.85Ϫ7.42 (m, 42 H, C6H5CH, C6H5CH2), 7.68, 7.81 (2 s, 2 H each,
4.24Ϫ4.36 (m, 5 H, 3-H, 4-H, 4Ј-H, 5Ј-H, 6Ј-Hb), 4.47 (dd, 1 H, 2-
H), 4.54, 4.60, 4.83 (3 d, 1 H each, C6H5CH2), 5.03 (s, 1 H, J1ЈЈЈ,2ЈЈЈ
C6H5CH), 5.18 (dd, 1 H, 3Ј-H), 5.31 (d, 1 H, C6H5CH2), 5.47 (s, (67.80 MHz, CDCl3): δ ϭ 13.4 (CH3S), 28.1 (CH2Lev), 29.6
1 H, CH3OC6H4CH), 5.59 (d, 1 H, 1-H), 5.73 (br. s, 1 H, 1Ј-H), (CH3Lev), 38.0 (CH2Lev), 54.8 (CH3OC6H4CH), 55.5 (CH3OC6H4),
6.70Ϫ6.96, 7.08Ϫ7.16 (2 m, 9 H and 4 H, CH3OC6H4, C6H5CH), 56.0 (C-2), 57.4 (C-2Ј), 67.0 (C-2ЈЈЈ), 64.7, 69.0Ϫ78.4 (other ring
DCPhth); J1,2 ϭ 8.3, J1Ј,2Ј ϭ 7.6, J1ЈЈ,2ЈЈ < 0.5, J2ЈЈ,3ЈЈ ϭ 3.0,
ϭ
1.7, JCH2 10.9, 11.6, 12.9 Hz.
ϭ
Ϫ
13C NMR
7.32Ϫ7.42 (m, 10 H, C6H5CH2), 7.70 and 7.88 (2 bs, 1 H each,
DCPhth); J1,2 ϭ 8.4, J2,3 ϭ 8.6, J2Ј,3Ј ϭ 3.3, J3Ј,4Ј ϭ 9.9, JCH2
C, C6H5CH2), 82.2 (C-1ЈЈ), 97.0 (C-1Ј), 97.4 (C-1), 99.1 (C-1ЈЈЈ),
100.3 (CH3OC6H4CH), 100.8 (C6H5CH), 114.2, 114.3, 118.5
ϭ
12.2, 12.4 Hz. Ϫ 13C NMR (67.80 MHz, CDCl3): δ ϭ 13.6 (CH3S), (CH3OC6H4, CH3OC6H4CH), 125.2Ϫ138.7 (C6H5CH2,C6H5CH),
20.8 (CH3CO), 55.3, 55.6 (2 CH3OC6H4), 56.2 (C-2), 64.6 (C-4Ј),
150.6, 155.3, 160.2, 165.6 (DCPhth, CH3OC6H4), 171.2
67.3 (C-6), 68.7 (C-6Ј), 70.1 (C-3Ј), 74.1 (C6H5CH2), 74.3 (C-2Ј), (CH2COO), 206.0 (CH3CO). Ϫ C117H112Cl4N2O27S (2152.1): C
75.0 (C-5), 75.4 (C6H5CH2), 75.6, 75.9, 77.2, 78.2 (C-3, C-4, C-
65.30, H 5.25, N 1.30; found C 64.83, H 5.28, N 1.23.
Eur. J. Org. Chem. 1999, 1367Ϫ1376
1374